Abstract

Purpose The heating characteristics of water-filtered infrared-A (wIRA) radiation were investigated in vivo in two body regions of healthy humans according to the quality standards of the European Society for Hyperthermic Oncology (ESHO) using an irradiance (infrared-A) of 146 W m−2 as recommended for clinical superficial hyperthermia (HT). Methods wIRA was applied to the abdominal wall and lumbar region for 60 min. Skin surface temperature was limited to ≤43 °C. Tissue temperatures were measured invasively at 1-min intervals before, during and after wIRA exposure using five fiber-optical probes at depths of 1–20 mm. Results Significant differences between body regions occurred during the heating-up phase at depths of 5–15 mm. Thermal steady states were reached at depths ≤5 mm after exposures of 5–6 min, and ≤20 mm after 20 min. On average, the minimum requirements of ESHO were exceeded in both regions by the following factors: ≈3 for the heating rate, ≈2 for the specific absorption rate and ≈1.4 for the temperature rise. Tissue depths with T 90 ≥ 40 °C and T 50 > 41 °C were ≤10 mm, and ≤20 mm for T max ≤ 43 °C. The temperature decay time after termination of irradiation was 1–5 min. Corresponding temperatures were ≤42.2 °C for CEM43 and ≤41.8 °C for CEM43 T 90, i.e., they are inadequate for direct thermal cell killing. Conclusions Thermography-controlled wIRA-HT complies with the ESHO criteria for superficial HT as a radiosensitizer and avoids the risk of thermal skin toxicity.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.